NEWS & EVENTS
News & Events
Press Release

Rhizen Pharmaceuticals Announces Out-licensing Agreement for TGR-1202, a Novel Next Generation PI3K-delta Inhibitor. (September 23, 2014)

Rhizen Pharmaceuticals S.A. announces data for their lead first-in-class inflammation/auto-immune assets, RP6503 and RP3128 in preclinical models at ERS 2014, September 06-10, Munich, Germany (September 03, 2014)

Rhizen Pharmaceuticals S.A. announces initiation of a "First in Human" Phase-1 trial of RP6530, a dual PI3K delta/gamma inhibitor, in patients with hematological malignancies (December 06, 2013)

Rhizen Pharmaceuticals S.A. announces preclinical presentations on RP6530, a dual PI3K delta/gamma inhibitor, for the treatment of hematological malignancies at the 55 th Annual Meeting of the American Society of Hematology, (December 07-10, 2013)

Rhizen Pharmaceuticals S.A Announces a Scientific Presentation on the PI3K-Delta Inhibitor, TGR-1202, at the XV International Workshop on Chronic Lymphocytic Leukemia at Cologne, Germany (September 09, 2013)

Rhizen Pharmaceuticals S.A. announces scientific presentations on the therapeutic potential of their lead dual PI3K delta/gamma inhibitor and CRAC channel inhibitor at the ERS Annual Conference at Barcelona, Spain, 07-11 September 2013 (September 06, 2013)

Rhizen Pharmaceuticals S.A. announces a scientific presentation on the therapeutic potential of their lead dual PI3K delta/gamma inhibitor in T-cell Lymphomas at the 18th Congress of European Hematology Association, 13-16 June 2013 (June 12, 2013)

Rhizen Pharmaceuticals S.A. announces a scientific presentation on its novel, inhaled, dual PI3K δ/γ inhibitor for the treatment of lung diseases at the American Thoracic Society International Conference in Philadelphia (May 14, 2013)

Rhizen Pharmaceuticals and TG Therapeutics Sign Joint Venture Collaboration Agreement for Worldwide Development and Commercialization of Novel Selective PI3K δ Kinase Inhibitors (August 16, 2012)


Events

Rhizen to present at European Respiratory Society 2014, September 06-10, Munich, Germany